We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPCC
1301
DELISTED
Infinity Property & Casualty C
IPCC
| $3.44M | 0.01% |
32,405
+2,800
| +9% | +$285K |
|
|
AAWW
1302
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $3.43M | 0.01% |
58,481
+8,708
| +17% | +$519K |
|
|
AMED
1303
DELISTED
Amedisys
AMED
| $3.43M | 0.01% |
65,009
+9,058
| +16% | +$477K |
|
1304
Papa John's
PZZA
$984M
| $3.43M | 0.01% |
61,053
-10,341
| -14% | -$643K |
|
1305
Sarepta Therapeutics
SRPT
$1.57B
| $3.42M | 0.01% |
61,542
-11,001
| -15% | -$583K |
|
1306
AAR Corp
AIR
$5.59B
| $3.42M | 0.01% |
86,943
+8,303
| +11% | +$334K |
|
|
BGC
1307
DELISTED
General Cable Corporation
BGC
| $3.41M | 0.01% |
115,290
+15,684
| +16% | +$371K |
|
1308
Nexstar Media Group
NXST
$5.82B
| $3.4M | 0.01% |
43,424
-9,486
| -18% | -$637K |
|
1309
Yelp
YELP
$1.45B
| $3.37M | 0.01% |
80,364
-12,606
| -14% | -$561K |
|
|
LPNT
1310
DELISTED
LifePoint Health, Inc.
LPNT
| $3.37M | 0.01% |
67,646
-265
| -0.4% | -$13.2K |
|
1311
TTM Technologies
TTMI
$12B
| $3.36M | 0.01% |
214,609
+28,557
| +15% | +$459K |
|
|
RPAI
1312
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $3.36M | 0.01% |
249,728
-2,972
| -1% | -$38.6K |
|
|
UNVR
1313
DELISTED
Univar Solutions Inc.
UNVR
| $3.35M | 0.01% |
108,380
-1,789
| -2% | -$53.3K |
|
1314
RBC Bearings
RBC
$17.4B
| $3.35M | 0.01% |
26,537
-4,662
| -15% | -$585K |
|
|
TYPE
1315
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.35M | 0.01% |
138,829
+9,158
| +7% | +$215K |
|
1316
Insight Enterprises
NSIT
$3.89B
| $3.34M | 0.01% |
87,323
+11,539
| +15% | +$472K |
|
|
KYNB
1317
Kyntra Bio
KYNB
$27.2M
| $3.34M | 0.01% |
2,820
-441
| -14% | -$553K |
|
|
EFII
1318
DELISTED
Electronics for Imaging
EFII
| $3.34M | 0.01% |
113,018
+9,293
| +9% | +$311K |
|
1319
Popular Inc
BPOP
$11.2B
| $3.33M | 0.01% |
93,827
-164
| -0.2% | -$5.67K |
|
1320
AZZ Inc
AZZ
$4.35B
| $3.32M | 0.01% |
64,912
+7,194
| +12% | +$340K |
|
|
CIM
1321
Chimera Investment
CIM
$1.04B
| $3.31M | 0.01% |
59,725
-5,824
| -9% | -$326K |
|
1322
Enovis
ENOV
$1.68B
| $3.3M | 0.01% |
48,327
-87
| -0.2% | -$5.86K |
|
|
SUM
1323
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.29M | 0.01% |
106,458
-19,327
| -15% | -$582K |
|
|
AXON
1324
Axon Enterprise
AXON
$42.5B
| $3.29M | 0.01% |
124,032
+13,596
| +12% | +$327K |
|
|
HMSY
1325
DELISTED
HMS Holdings Corp.
HMSY
| $3.29M | 0.01% |
193,901
+26,849
| +16% | +$470K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.